Technology
Health
Pharmaceutical

Mitsubishi Tanabe Pharma

$11.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.24 (2.08%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell MTZPY and other stocks, options, ETFs, and crypto commission-free!

About

Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. Read More The company operates through Pharmaceuticals segment. Mitsubishi Tanabe Pharma was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan. MTZPY is listed on the Pink Current market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com).

Employees
7,187
Headquarters
Osaka, Osaka
Founded
Market Cap
6.62B
Price-Earnings Ratio
15.50
Dividend Yield
2.15
Average Volume
39.98K
High Today
$11.84
Low Today
$11.56
Open Price
$11.56
Volume
27.41K
52 Week High
$19.82
52 Week Low
$11.13

Collections

Technology
Health
Pharmaceutical
2013 IPO
Asia (Non-China)
Asia
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.